Unisom labeling
This article was originally published in The Tan Sheet
Executive Summary
Updates to "Drug Facts" labeling for Pfizer's OTC sleep aid cleared by FDA June 3 through supplemental NDAs 18-066/S-011 and S-013. Changes provide for "new labeling for two additional package sizes (40- and 64-count) and revised labeling for four package sizes (8-, 16-, 32- and 48-count)," agency's approval letter states...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.